Cargando…
EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study
Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. M...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396324/ https://www.ncbi.nlm.nih.gov/pubmed/34449695 http://dx.doi.org/10.3390/pharmacy9030137 |
_version_ | 1783744347558117376 |
---|---|
author | Deters, Maira Anna Obarcanin, Emina Schwender, Holger Läer, Stephanie |
author_facet | Deters, Maira Anna Obarcanin, Emina Schwender, Holger Läer, Stephanie |
author_sort | Deters, Maira Anna |
collection | PubMed |
description | Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. Methods: To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. Results: The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. Conclusions: This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus. |
format | Online Article Text |
id | pubmed-8396324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83963242021-08-28 EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study Deters, Maira Anna Obarcanin, Emina Schwender, Holger Läer, Stephanie Pharmacy (Basel) Article Background: A 2016 meta-analysis of pharmaceutical care for patients with diabetes mellitus showed that the following four components were most effective: (a) individual goal setting, (b) sending feedback to the physician, (c) reviewing the medication, and (d) reviewing blood glucose measurements. Methods: To formulate a hypothesis regarding the effect of these four pharmaceutical care components on glycemic control in patients with diabetes mellitus and the feasibility of these components in practice. Ten patients with type 2 diabetes were included in the case series and received medication therapy management over four months. Results: The four care components were feasible in everyday practice and could be implemented within one patient visit. The average visits were 49 and 28 min at the beginning and end of the study, respectively. The glycated hemoglobin values did not change over the study period, though the fasting blood glucose decreased from 142 to 120 mg/dl, and the number of unsolved drug-related problems decreased from 6.9 to 1.9 per patient by the study end. Conclusions: This case series supports the hypothesis that community pharmacists can implement structured pharmaceutical care in everyday pharmacy practice for patients with type 2 diabetes mellitus. MDPI 2021-08-09 /pmc/articles/PMC8396324/ /pubmed/34449695 http://dx.doi.org/10.3390/pharmacy9030137 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Deters, Maira Anna Obarcanin, Emina Schwender, Holger Läer, Stephanie EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study |
title | EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study |
title_full | EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study |
title_fullStr | EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study |
title_full_unstemmed | EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study |
title_short | EMDIA Case Series—Effective Medication Therapy Management (MTM) for Diabetes Type 2 Patients—A Proof of Concept Study |
title_sort | emdia case series—effective medication therapy management (mtm) for diabetes type 2 patients—a proof of concept study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396324/ https://www.ncbi.nlm.nih.gov/pubmed/34449695 http://dx.doi.org/10.3390/pharmacy9030137 |
work_keys_str_mv | AT detersmairaanna emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy AT obarcaninemina emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy AT schwenderholger emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy AT laerstephanie emdiacaseserieseffectivemedicationtherapymanagementmtmfordiabetestype2patientsaproofofconceptstudy |